Freestone Grove Partners LP Invests $15.21 Million in Ralliant Corporation $RAL

Freestone Grove Partners LP bought a new stake in shares of Ralliant Corporation (NYSE:RAL) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 206,590 shares of the company’s stock, valued at approximately $15,211,000.

Other hedge funds have also recently made changes to their positions in the company. Danske Bank A S bought a new stake in Ralliant during the 4th quarter valued at about $25,000. Dunhill Financial LLC bought a new position in Ralliant in the 2nd quarter worth about $25,000. Palisade Asset Management LLC purchased a new position in shares of Ralliant during the third quarter worth approximately $26,000. Allworth Financial LP raised its stake in shares of Ralliant by 134.4% during the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock valued at $26,000 after acquiring an additional 293 shares in the last quarter. Finally, BOKF NA bought a new stake in shares of Ralliant during the third quarter valued at approximately $29,000.

Insider Buying and Selling at Ralliant

In other news, CEO Tamara S. Newcombe sold 12,936 shares of the stock in a transaction on Friday, August 14th. The stock was sold at an average price of $71.79, for a total transaction of $928,675.44. Following the completion of the sale, the chief executive officer owned 251,967 shares in the company, valued at approximately $18,088,710.93. This represents a 4.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the completion of the sale, the senior vice president directly owned 31,668 shares of the company’s stock, valued at $2,280,096. The trade was a 16.07% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on RAL shares. Morgan Stanley increased their price objective on Ralliant from $68.00 to $85.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 23rd. Royal Bank Of Canada raised their price objective on Ralliant from $71.00 to $73.00 and gave the stock a “sector perform” rating in a report on Friday, July 31st. TD Cowen upped their target price on Ralliant from $70.00 to $80.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Vertical Research downgraded Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target on the stock. in a research report on Wednesday, May 27th. Finally, BMO Capital Markets started coverage on Ralliant in a research report on Monday, July 20th. They set a “market perform” rating and a $78.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $75.70.

Ralliant Stock Performance

RAL stock opened at $63.44 on Friday. Ralliant Corporation has a one year low of $37.27 and a one year high of $75.41. The firm has a market cap of $7.02 billion, a price-to-earnings ratio of -5.85, a PEG ratio of 2.37 and a beta of 1.60. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. The firm has a 50-day simple moving average of $68.53 and a two-hundred day simple moving average of $56.39.

Ralliant (NYSE:RAL) last issued its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.63 by $0.05. The firm had revenue of $567.80 million for the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, equities analysts forecast that Ralliant Corporation will post 2.87 EPS for the current fiscal year.

Ralliant Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date is Tuesday, September 8th. Ralliant’s dividend payout ratio (DPR) is -1.84%.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.